Skip to main content

Healthcare Cold Chain Logistics Market is Increasing Gradually at a Healthy CAGR of 7.54% During Forecast to 2023

Healthcare Cold Chain Logistics Market Size, Share, Growth, Global Analysis, Trends Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) – Global Forecast by 2023
Market Synopsis:
However, cold chain logistics are penetrating the healthcare sector at a moderate rate due to the sophisticated and elaborate process; especially in developing countries. Other factors obstructing the growth of the global healthcare cold chain logistics market include a lack of infrastructure and a proper regulatory framework in underdeveloped countries although governments in some emerging economies are also taking corrective action to augment healthcare cold chain logistics services, fueling market growth.
Demand for cold chain logistics in the healthcare sector is increasing with time and the global Healthcare Cold Chain Logistics Market Statistics is expected to grow with a 7.54% CAGR during the forecast period 2018-2023 predicts Market Research Future (MRFR).
The healthcare cold chain logistics also assists in monitoring environmental fluctuations and hence, is beneficial for transporting thermal-sensitive products vaccines, serums, and others. Cold chain provides real-time information, which is an additional factor that is spurring its rate of adoption in several healthcare organizations, hence, expected to amplify the healthcare cold chain logistics market expansion. The need for well-managed transportation of biological products is likely to prompt the healthcare cold chain logistics market growth. Furthermore, cold chain plays a crucial role in streamlining clinical trials procedures, that is likely to boost the healthcare cold chain logistics market growth. Various mergers and acquisitions among market players are also expected to aid in generating revenues for the market. However, the lack of effort in maintaining consistency throughout the process can hinder the market expansion.

Key players:
  • AmerisourceBergen Corporation
  • American Airlines
  • DB Schenker
  • FedEx
  • Marken
  • Cavalier Logistics
  • KUEHNE + NAGEL
  • DHL international GmbH

Segmental Analysis:

  • The MRFR report includes a detailed segmentalanalysis of the market based on product type, storage techniques, end user and services.
  • Based on product type, the healthcare cold chain logistics market is segmented into clinical trial materials, vaccines, biopharmaceuticals, and others.
  • Based on product type, the market has been segmented into clinical trial materials, vaccines, biopharmaceuticals, and others.
  • Based on services, the market has been segmented into packaging, transportation, storage and others
  • Based on storage techniques, the market has been segmented into liquid nitrogen, electrical refrigeration, gel packs, dry ice and others.
  • Based on end user, the market has been segmented into research institutes, hospitals and clinics, biopharmaceuticalcompanies, and others.

Regional Analysis:
Based on the region, the healthcare cold chain logistics market been segmented into Latin America, North America, Europe, Asia Pacific, Europe, and the Middle East Asia and Africa.
In North and Latin America, the healthcare cold chain logistics market is expected to lead in the global market over the assessment period. Europe, followed by Asia Pacific, the regions are likely to hold a significant share of the market. Factors like the existence of powerful pharmaceutical companies and the increase in number of mergers and acquisitions among them are fueling the healthcare cold chain logistics market growth in these regions.
Industry Update
April 2019: Tata Motors recently invested in a pharmaceutical cold chain specialist, Kool-ex, is experiencing substantial growth. Owing to the increasing demand for cold chain logistics in the pharma sector, Tata Motors is planning to invest Rs 140 crore in the next two years to double its fleet to 800 reefer trucks


Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more